// App-Quantinova.ai

: Autoimmunity Checkpoints As Therapeutic Targets in B-Cell Malignancies

Researchers

Presenter

  • Zhengshan Chen

Principal Investigators

  • Markus Muschen

Medical Centers

  • Department of Systems Biology, City of Hope Comprehensive Cancer Center, Monrovia, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B cell lymphomas

  • Lymphomas

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved